AIDS

1. HONGE BL, Andersen MN, Petersen MS, Jespersen S, et al
   Monocyte phenotype and extracellular vesicles in HIV-1, HIV-2, and HIV-1/2 dual infection.
   AIDS. 2023 Jul 18. doi: 10.1097/QAD.0000000000003660.
   

   >> Share

   
   
2. DICKEY BL, Putney RM, Suneja G, Kresovich JK, et al
   Differences in epigenetic age by HIV status among patients with a non-AIDS defining cancer.
   AIDS. 2023 Jul 18. doi: 10.1097/QAD.0000000000003661.
   

   >> Share

   
   
3. GAO H, Zhang J, Yang X, Chen S, et al
   The incidence and dynamic risk factors of chronic kidney disease among people living with HIV - A population-based Cohort Study.
   AIDS. 2023 Jul 19. doi: 10.1097/QAD.0000000000003662.
   

   >> Share

   
   
4. MUULA GK, Bosomprah S, Sinkala E, Nsokolo B, et al
   HBV viral replication markers and hepatic fibrosis in untreated chronic HBV infection with and without HIV coinfection in Zambia.
   AIDS. 2023 Jul 18. doi: 10.1097/QAD.0000000000003659.
   

   >> Share

   
   
5. MARTINELLO M, Carson JM, Van Der Valk M, Rockstroh JK, et al
   Reinfection incidence and risk among people treated for recent hepatitis C virus infection: the react study.
   AIDS. 2023 Jul 18. doi: 10.1097/QAD.0000000000003651.
   

   >> Share

   
   
6. PALICH R, Hentzien M, Hocqueloux L, Duvivier C, et al
   Country of birth is associated with discrepancies in the prescription of two-drug regimens in successfully treated people living with HIV in France.
   AIDS. 2023 Jul 14. doi: 10.1097/QAD.0000000000003657.
   

   >> Share

   
   
7. DINH S, Malmstrom S, Moller IK, Yilmaz A, et al
   Extracutaneous Kaposi sarcoma risk remains higher in people with HIV in the post-ART era: a nation-wide population-based study.
   AIDS. 2023 Jul 14. doi: 10.1097/QAD.0000000000003658.
   

   >> Share

   
   
8. MASICH AM, Gomes D, Higginson RT, Morgan Z, et al
   HIV virologic response and baseline genotypic resistance in a long-acting cabotegravir/rilpivirine initiation program.
   AIDS. 2023;37:1641-1642.
   

   >> Share

   
   
9. 
   Incidence and severity of SARS-CoV-2 infection in children and young people with HIV in Europe.
   AIDS. 2023;37:1633-1639.
   

   >> Share

   
   
10. WASHAYA T, Manasa J, Kouamou V
    HIV drug resistance monitoring in the era of dolutegravir and injectable long-acting cabotegravir in resource-limited settings.
    AIDS. 2023;37:1629-1631.
    

    >> Share

    
    
11. AHMAD A, Samarani S, Costiniuk CT
    Antibody and T-cell responses elicited by coronavirus disease 2019 vaccination in people with HIV-1: the case of late presenters.
    AIDS. 2023;37:1625-1627.
    

    >> Share

    
    
12. FILIP I
    Evolving relationship between HIV infection and inflammatory bowel disease adds layer of complexity to HIV management.
    AIDS. 2023;37:N7-N8.
    

    >> Share

    
    
13. MYSTAKELIS HA, Wilson E, Laidlaw E, Poole A, et al
    An open label randomized controlled trial of atorvastatin versus aspirin in elite controllers and antiretroviral-treated people with HIV.
    AIDS. 2023 Jul 14. doi: 10.1097/QAD.0000000000003656.
    

    >> Share

    
    

    
    AIDS Res Hum Retroviruses

14. COSSARINI F, Aberg J, Chen BK, Mehandru S, et al
    Viral persistence in the Gut-Associated Lymphoid Tissue and barriers to HIV cure.
    AIDS Res Hum Retroviruses. 2023 Jul 14. doi: 10.1089/AID.2022.0180.
    

    >> Share

    
    
15. MARTINEZ DE VICTORIA-CARAZO J, Garcia-Ceberino PM, de Salazar-Gonzalez A, Faro-Miguez N, et al
    MONKEYPOX VIRUS (MPXV) INFECTION AND SEXUALLY TRANSMITTED INFECTIONS (STIs): A CROSS-SECTIONAL STUDY FROM A SECONDARY HOSPITAL IN THE MAY-SEPTEMBER 2022 INTERNATIONAL OUTBREAK.
    AIDS Res Hum Retroviruses. 2023 Jul 14. doi: 10.1089/AID.2023.0016.
    

    >> Share

    
    
16. QUINA M, Ramos D, Silva C, Padua E, et al
    Diversity of Human T-Lymphotropic Virus type 1 Cosmopolitan subtype (HTLV-1a) circulating in infected-residents in Portugal.
    AIDS Res Hum Retroviruses. 2023 Jul 18. doi: 10.1089/AID.2023.0026.
    

    >> Share

    
    
17. DUBE K
    RFS Proudly Announces the 2022 Award Recipient for AIDS Research and Human Retroviruses.
    AIDS Res Hum Retroviruses. 2023;39:317.
    

    >> Share

    
    

    
    Am J Epidemiol

18. DEAN LT
    Correcting the Narrative toward More Diverse & Inclusive Institutions.
    Am J Epidemiol. 2023 Jul 19:kwad160. doi: 10.1093.
    

    >> Share

    
    

    
    BMC Cancer

19. MUSA J, Maiga M, Green SJ, Magaji FA, et al
    Vaginal microbiome community state types and high-risk human papillomaviruses in cervical precancer and cancer in North-central Nigeria.
    BMC Cancer. 2023;23:683.
    

    >> Share

    
    

    
    BMC Pediatr

20. ROSE PC, Cotton MF, Otwombe K, Innes S, et al
    Liver transient elastography values in healthy South African children.
    BMC Pediatr. 2023;23:355.
    

    >> Share

    
    

    
    BMJ

21. WISE J
    Ending AIDS by 2030 is a political choice, says UN agency.
    BMJ. 2023;382:p1667.
    

    >> Share

    
    

    
    Clin Infect Dis

22. VOLLMOND CV, Tetens MM, Paulsen FW, Gerstoft J, et al
    Risk of Depression in People With HIV: A nationwide population-based matched cohort study.
    Clin Infect Dis. 2023 Jul 19:ciad415. doi: 10.1093.
    

    >> Share

    
    
23. GARCIA R, Warming PE, Hansen CJ, Rajan D, et al
    Out-of-Hospital Cardiac Arrest in individuals with Human Immunodeficiency Virus infection - A nationwide population-based cohort study.
    Clin Infect Dis. 2023 Jul 14:ciad422. doi: 10.1093.
    

    >> Share

    
    

    
    HIV Med

24. DRAGO F, Soshnik-Schierling L, Cabling ML, Pattarabanjird T, et al
    Characterizing blood pressure trajectories in people living with HIV following antiretroviral therapy: A systematic review.
    HIV Med. 2023 Jul 20. doi: 10.1111/hiv.13524.
    

    >> Share

    
    

    
    J Clin Immunol

25. LI W, Sun Y, Yu L, Chen R, et al
    Multiple Immune Defects in Two Patients with Novel DOCK2 Mutations Result in Recurrent Multiple Infection Including Live Attenuated Virus Vaccine.
    J Clin Immunol. 2023;43:1193-1207.
    

    >> Share

    
    

    
    J Clin Invest

26. MCMYN NF, Varriale J, Fray EJ, Zitzmann C, et al
    The latent reservoir of inducible, infectious HIV-1 does not decrease despite decades of antiretroviral therapy.
    J Clin Invest. 2023 Jul 18:e171554. doi: 10.1172/JCI171554.
    

    >> Share

    
    

    
    J Infect Dis

27. FRENCH MA
    The Immunopathogenesis of Immune Reconstitution Inflammatory Syndrome Has Become Clearer, but More Complex.
    J Infect Dis. 2023;228:106-110.
    

    >> Share

    
    

    
    J Med Virol

28. LARA-AGUILAR V, Crespo-Bermejo C, Llamas-Adan M, Grande-Garcia S, et al
    HCV spontaneous clearers showed low senescence profile in people living with HIV under long ART.
    J Med Virol. 2023;95:e28955.
    

    >> Share

    
    
29. GONG X, Chi H, Xia Z, Yang G, et al
    Advances in HPV-associated tumor management: Therapeutic strategies and emerging insights.
    J Med Virol. 2023;95:e28950.
    

    >> Share

    
    
30. ZHANG J, Zhang Y, Khanal S, Cao D, et al
    Synthetic gRNA/Cas9 ribonucleoprotein targeting HBV DNA inhibits viral replication.
    J Med Virol. 2023;95:e28952.
    

    >> Share

    
    

    
    Nat Med

31. GUILAMO-RAMOS V, Thimm-Kaiser M, Benzekri A
    Community-engaged Mpox vaccination provides lessons for equitable health care in the United States.
    Nat Med. 2023 Jul 19. doi: 10.1038/s41591-023-02447.
    

    >> Share

    
    
32. SERRANO-VILLAR S, Tincati C, Raju SC, Saenz JS, et al
    Microbiome-derived cobalamin and succinyl-CoA as biomarkers for improved screening of anal cancer.
    Nat Med. 2023;29:1738-1749.
    

    >> Share

    
    

    
    Nature

33. AUGUSTO DG, Murdolo LD, Chatzileontiadou DSM, Sabatino JJ Jr, et al
    A common allele of HLA is associated with asymptomatic SARS-CoV-2 infection.
    Nature. 2023 Jul 19. doi: 10.1038/s41586-023-06331.
    

    >> Share

    
    

    
    PLoS One

34. FEKADU G, Wang Y, You JHS
    Standard diagnostics with and without urine-based lipoarabinomannan testing for tuberculosis disease in HIV-infected patients in a high-burden setting-A cost-effectiveness analysis.
    PLoS One. 2023;18:e0288605.
    

    >> Share

    
    
35. BRADSHAW D, Abramowicz I, Bremner S, Verma S, et al
    Hepmarc: A 96 week randomised controlled feasibility trial of add-on maraviroc in people with HIV and non-alcoholic fatty liver disease.
    PLoS One. 2023;18:e0288598.
    

    >> Share

    
    
36. MAYANJA Y, Rida W, Kimani J, Ssetala A, et al
    Hepatitis B status and associated factors among participants screened for simulated HIV vaccine efficacy trials in Kenya and Uganda.
    PLoS One. 2023;18:e0288604.
    

    >> Share

    
    
37. TUKEI VJ, Herrera N, Masitha M, Masenyetse L, et al
    Optimizing antiretroviral therapy for children living with HIV: Experience from an observational cohort in Lesotho.
    PLoS One. 2023;18:e0288619.
    

    >> Share

    
    
38. BYANOVA KL, Fitzpatrick J, Jan AK, McGing M, et al
    Isolated abnormal diffusing capacity for carbon monoxide (iso downward arrowDLco) is associated with increased respiratory symptom burden in people with HIV infection.
    PLoS One. 2023;18:e0288803.
    

    >> Share

    
    
39. ORSER L, O'Byrne P, Holmes D
    Patient perspectives on the role of nurses in HIV pre-exposure prophylaxis care (PrEP-RN).
    PLoS One. 2023;18:e0288283.
    

    >> Share

    
    
40. AJIBOYE AS, Eshetu F, Lulseged S, Getaneh Y, et al
    Predictors of HIV testing among youth 15-24 years in urban Ethiopia, 2017-2018 Ethiopia population-based HIV impact assessment.
    PLoS One. 2023;18:e0265710.
    

    >> Share

    
    
41. NATUKUNDA E, Szubert A, Otike C, Namyalo I, et al
    Bone mineral density among children living with HIV failing first-line anti-retroviral therapy in Uganda: A sub-study of the CHAPAS-4 trial.
    PLoS One. 2023;18:e0288877.
    

    >> Share

    
    
42. MEKONNEN E, Arega M, Belay DM, Birhanu D, et al
    Time to death and its predictors among under-five children on antiretroviral treatment in public hospitals of Addis Ababa, Addis Ababa, Ethiopia, a retrospective follow up study.
    PLoS One. 2023;18:e0288475.
    

    >> Share

    
    
43. SAXENA V, Xu A, Kinley K, Tsheten T, et al
    Stigma and discrimination against transgender men in Bhutan.
    PLoS One. 2023;18:e0287745.
    

    >> Share

    
    
44. HUWA J, Tweya H, Mureithi M, Kiruthu-Kamamia C, et al
    "It reminds me and motivates me": Human-centered design and implementation of an interactive, SMS-based digital intervention to improve early retention on antiretroviral therapy: Usability and acceptability among new initiates in a high-volume, public
    PLoS One. 2023;18:e0278806.
    

    >> Share

    
    
45. NAMBUSI K, Gbolahan A, Maureen SM, Tsholofelo RT, et al
    Youth and healthcare workers' perspectives on the feasibility and acceptability of self-testing for HIV, Hepatitis and Syphilis among young people: Qualitative findings from a pilot study in Gaborone, Botswana.
    PLoS One. 2023;18:e0288971.
    

    >> Share

    
    

    
    PLoS Pathog

46. BRUCE JW, Park E, Magnano C, Horswill M, et al
    HIV-1 virological synapse formation enhances infection spread by dysregulating Aurora Kinase B.
    PLoS Pathog. 2023;19:e1011492.
    

    >> Share

    
    

    
    Vaccine

47. MUNOZ FM, Posavad CM, Richardson BA, Badell ML, et al
    COVID-19 booster vaccination during pregnancy enhances maternal binding and neutralizing antibody responses and transplacental antibody transfer to the newborn.
    Vaccine. 2023 Jun 13:S0264-410X(23)00698-9. doi: 10.1016/j.vaccine.2023.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share